Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SHA/688016 stock hub

SHA/688016 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/688016is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.3B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/688016

In the news

Latest news · SHA/688016

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.6

P25 17.1P50 24.2P75 37.8

Trailing P/E20.8

P25 23.5P50 41.3P75 83.2

ROE14.3

P25 -0.9P50 4.1P75 8.8

ROIC25.2

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/688016 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

CNY

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	822
Employees Change	-4%
Employees Change Percent	-0.48
Enterprise value	CNY 10.2B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Devices
Isin	CNE100003MJ5
Last refreshed	2026-05-10
Market cap	CNY 12.3B
Price	CNY 102
Price currency	CNY
Rev Per Employee	1,689,391.07x
Sector	Healthcare
Sic	3842
Symbol	sha/688016
Website	https://www.endovastec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.79%
EV Earnings	17.39x
EV/EBIT	16.56x
EV/EBITDA	14.63x
EV/FCF	32.8x
EV/Sales	7.37x
FCF yield	2.54%
Forward P/E	17.56x
P/B ratio	2.9x
P/E ratio	20.82x
P/S ratio	8.85x
PE Ratio10 Y	50.79x
PE Ratio3 Y	26.29x
PE Ratio5 Y	37.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	44.61%
EBITDA Margin	49.63%
FCF margin	22.46%
Gross margin	71.31%
Gross Profit	CNY 990.3M
Gross Profit Growth	18.84%
Gross Profit Growth Q	17.08%
Gross Profit Growth3 Y	12.94%
Gross Profit Growth5 Y	17.19%
Net Income	CNY 588.5M
Net Income Growth	31.53%
Net Income Growth Q	19.44%
Net Income Growth Quarters	2%
Net Income Growth Years	9%
Net Income Growth3 Y	18%
Net Income Growth5 Y	18.04%
Pretax Margin	49.14%
Profit Margin	42.38%
Profit Per Employee	CNY 715,974
Profitable Years	10
ROA	8.36
Roa5y	10.34
ROCE	14.18
ROE	14.26
Roe5y	17.71
ROIC	25.2
Roic5y	52.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	20.1%
Cagr3y	-2.06%
Cagr5y	-12.44%
Div CAGR3	2.25%
Div CAGR5	22.26%
EPS Growth	34.8
EPS Growth Q	21.91
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	13.53
EPS Growth5 Y	15.37
FCF Growth5 Y	5.49%
OCF Growth	169.59%
OCF Growth Q	-73.31%
OCF Growth3 Y	20.88%
OCF Growth5 Y	15.08%
Revenue Growth	17.64x
Revenue Growth Q	11.45x
Revenue Growth Quarters	3x
Revenue Growth Years	9x
Revenue Growth3 Y	14.54x
Revenue Growth5 Y	19.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.3
Assets	CNY 4.8B
Cash	CNY 2.1B
Current Assets	CNY 2.9B
Current Liabilities	CNY 424.7M
Debt	CNY 4.6M
Debt EBITDA	CNY 0.01
Debt Equity	CNY 0
Debt FCF	CNY 0.01
Equity	CNY 4.2B
Interest Coverage	458.1
Liabilities	CNY 554.4M
Long Term Assets	CNY 1.8B
Long Term Liabilities	CNY 129.7M
Net Cash	CNY 2.1B
Net Cash By Market Cap	CNY 16.9
Net Cash Growth	4.6%
Net Debt EBITDA	CNY -3.01
Net Debt Equity	CNY -0.49
Net Debt FCF	CNY -6.66
Tangible Book Value	CNY 3.4B
Tangible Book Value Per Share	CNY 27.71
WACC	5.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.94
Inventory Turnover	1.54
Net Working Capital	CNY 440.7M
Quick ratio	6.2
Working Capital	CNY 2.5B
Working Capital Turnover	CNY 0.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.42%
Dividend Growth	-64.61%
Dividend Growth Years	0%
Dividend per share	CNY 2.3
Dividend Years	6
Dividend Yield	2.26%
Last Dividend	CNY 1.3
Payout Frequency	Semi-Annual
Payout Ratio	34.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	20.09%
200-day SMA	102.5
3Y total return	-6.06%
50-day SMA	103.5
50-day SMA vs 200-day SMA	50over200
5Y total return	-48.53%
All Time High	322.1
All Time High Change	-68.44%
All Time High Date	2021-07-05
All Time Low	67.79
All Time Low Change	50%
All Time Low Date	2019-07-22
ATR	2.69
Beta	0.19
Beta1y	0.22
Beta2y	0.55
Ch YTD	10.93
High	102.9
High52	124.3
High52 Date	2025-08-21
High52ch	-18.2%
Low	100.9
Low52	84.1
Low52 Date	2025-05-19
Low52ch	20.9%
Ma50ch	-1.76%
Price vs 200-day SMA	-0.83%
RSI	51.42
RSI Monthly	48.53
RSI Weekly	51.67
Sharpe ratio	0.58x
Sortino ratio	1.15
Total Return	4.69%
Tr YTD	10.93
Tr1m	0.25%
Tr1w	0.88%
Tr3m	3.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 619.5M
Operating Income Growth	34.61
Operating Income Growth Q	27.8
Operating Income Growth3 Y	17.83
Operating Income Growth5 Y	18.67
Operating margin	44.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	71,145,204%
Net Borrowing	-153,975,167
Shares Institutions	13.3%
Shares Out	120,841,074
Shares Qo Q	-0%
Shares Yo Y	-2.42%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 311.9M
Average Volume	1,905,722.6x
Bv Per Share	34.87
CAPEX	CNY -231.8M
Ch1m	0.25
Ch1w	0.88
Ch1y	18.14
Ch3m	3.78
Ch3y	-11.75
Ch5y	-52.3
Ch6m	4.04
Change	0.36%
Change From Open	0.46
Close	101.3
Days Gap	-0.11
Depreciation Amortization	69,697,036
Dollar Volume	179,609,890.6
Earnings Date	2026-04-30
EBIT	CNY 619.5M
EBITDA	CNY 689.2M
EPS	CNY 4.88
F Score	6
FCF	CNY 311.9M
FCF EV Yield	3.05x
FCF Per Share	CNY 2.58
Financing CF	-403,401,557
Fiscal Year End	December
Founded	2,012
Goodwill	452,614,119
Graham Number	61.89587
Graham Upside	-39.13
Income Tax	CNY 103.1M
Investing CF	-145,066,755
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2024-05-14
Last Split Type	Forward
Lynch Fair Value	CNY 88.09
Lynch Upside	-13.36
Ma150	100.1
Ma150ch	1.54%
Ma20	100.4
Ma20ch	1.3%
Net CF	-667,352
Next Earnings Date	2026-08-26
Open	101.2
P FCF Ratio	39.39
P OCF Ratio	22.6
Payment Date	2025-10-17
Position In Range	38.42
Ppne	735,766,241
Price Date	2026-05-08
Price EBITDA	CNY 17.83
Ptbv Ratio	3.67
Relative Volume	0.94x
Revenue	1,388,679,457x
Tax By Revenue	7.43x
Tax Rate	15.11%
Tr6m	4.04%
Volume	1,766,423

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/688016 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.3%

$2.30 annual per share

Payout ratio

+34.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+22.3%

0 consecutive years of growth

Total shareholder yield

+4.7%

Dividend yield + buyback yield combined

Performance

SHA/688016 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/688016?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.4%

Negative means the company is buying back shares.

Technical

SHA/688016 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.4

Neutral momentum band

Price vs 200-day MA

-0.8%

50/200-day relationship not available

Beta (5Y)

0.19

Less volatile than the market

Sharpe ratio

0.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/688016

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688016 stock rating?

sha/688016 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688016 analysis?

The full report lives at /stocks/sha/688016/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688016?

The latest report frames sha/688016 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688016 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.